KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Research & Development: 2019-2024

Historic Research & Development for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $424.1 million.

  • Ginkgo Bioworks Holdings' Research & Development fell 9.94% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.0 million, marking a year-over-year decrease of 41.90%. This contributed to the annual value of $424.1 million for FY2024, which is 26.96% down from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Research & Development stood at $424.1 million, which was down 26.96% from $580.6 million recorded in FY2023.
  • Ginkgo Bioworks Holdings' 5-year Research & Development high stood at $1.1 billion for FY2021, and its period low was $159.8 million during FY2020.
  • Moreover, its 3-year median value for Research & Development was $580.6 million (2023), whereas its average is $685.8 million.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 619.59% in 2021, then slumped by 44.84% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Research & Development stood at $159.8 million in 2020, then soared by 619.59% to $1.1 billion in 2021, then decreased by 8.44% to $1.1 billion in 2022, then slumped by 44.84% to $580.6 million in 2023, then declined by 26.96% to $424.1 million in 2024.